SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-15-064625
Filing Date
2015-11-12
Accepted
2015-11-12 15:04:38
Documents
9
Period of Report
2015-11-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v424572_8k.htm 8-K 16460
2 EXHIBIT 99.1 v424572_ex99-1.htm EX-99.1 3926
3 GRAPHIC logo.jpg GRAPHIC 8938
4 GRAPHIC image_001.jpg GRAPHIC 252142
5 GRAPHIC image_002.jpg GRAPHIC 246117
6 GRAPHIC image_003.jpg GRAPHIC 214428
7 GRAPHIC image_004.jpg GRAPHIC 302325
8 GRAPHIC image_005.jpg GRAPHIC 296183
9 GRAPHIC image_006.jpg GRAPHIC 269074
  Complete submission text file 0001144204-15-064625.txt   2211269
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 151223802
SIC: 2834 Pharmaceutical Preparations